Berkeley Capital Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
VCM
VPM
Berkeley Capital Partners's MDT Position: Q1 2026 in Review
Berkeley Capital Partners reduced its Medtronic (MDT) stake by 3.3% in Q1 2026, selling an estimated $90.3K and leaving 27,259 shares worth $2.36M. The position accounts for 0.55% of the portfolio, ranked #32.
Berkeley Capital Partners first reported a position in MDT in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.05M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Berkeley Capital Partners held 27,259 shares of Medtronic worth $2.36M as of Q1 2026.
- Berkeley Capital Partners sold 943 Medtronic shares in Q1 2026, an estimated $90.3K.
- Medtronic made up 0.55% of Berkeley Capital Partners's portfolio in Q1 2026, its #32 holding.
- Berkeley Capital Partners first reported a position in Medtronic in Q4 2020 and has held it in 22 quarters since.
- Berkeley Capital Partners's Medtronic position peaked at $3.05M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Berkeley Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.